This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. (IK Ca ) channels subject to activation by DCEBIO and to inhibition by TRAM-34 or clotrimazole were functionally expressed in these cells. Unlike cisplatin, OXAL decreased the probability of IK Ca -channel openings in a concentration-dependent manner with an IC 50 value of 67 µM. No significant change in single-channel conductance of IK Ca channels in the presence of OXAL was demonstrated. Neither large-conductance Ca 2+ -activated K + channels nor inwardly rectifying K + currents in these cells were affected in the presence of OXAL. OXAL also suppressed the proliferation and migration of 13-06-MG cells in a concentration-and time-dependent manner. OXAL reduced IK Ca -channel activity in LoVo colorectal cancer cells. Taken together, the inhibition by OXAL of IK Ca channels would conceivably be an important mechanism through which it acts on the functional activities of glioma cells occurring in vivo.
Introduction
Glioblastoma multiforme is a cancer with dismal prognosis and the relative short life expectancy for its victims was disappointing despite recent extensive treatment [1] . Ion currents inherent in malignant glioma cells have been increasingly reported to influence the behavior of these cells [2] [3] [4] [5] [6] [7] [8] [9] [10] . Specifically, numerous reports demonstrated that any perturbations of functional expression in intermediate-conductance Ca 2+ -activated K + (IK Ca ) channels enriched in glioma cells or other types of neoplastic cells are capable of interfering with invasiveness or progression of malignant tumors [4, 5, [11] [12] [13] [14] [15] [16] . Alternatively, oxaliplatin (OXAL) belongs to a family of platinum-based chemotherapeutic compounds and is one of the most active drugs in many types of solid tumors encompassing gliomas [17] [18] [19] . However, whether OXAL or other similar structurally-related compounds can interact with ion currents and to alter malignant behaviors in these cells is incompletely understood, in spite of its ability to produce multiple pharmacological activities [17] .
The IK Ca channels (also known as K Ca 3.1, SK4, IKCa1 or KCNN4) which are encoded by the KCNN4 gene have been increasingly investigated in many non-excitable or neoplastic cells concerning their contributory roles in cell behaviors including hormonal secretion, cell migration, cell proliferation, and regulation of Ca 2+ influx and/or K + efflux [2, 8, 9, 13-15, 20, 21] . More importantly, the pharmacological modulators of IK Ca (K Ca 3.1) channels may represent an attractive therapeutic approach to a variety of tumors including gliomas [2, 4, 9, 15, 22] . However, whether OXAL or other related drugs exert any effects on the activity of IK Ca channels is not thoroughly understood, despite the fact that it can block K + currents [23] . Therefore, in this study, we attempted to investigate whether, in human 13-06-MG glioma cells, OXAL exerts any effects on ion currents including K + currents (I K ) and IK Ca channels, to determine how this drug interacts with IK Ca channel to change I K amplitude, and to address the issue of how this drug has any effects on the growth of these cells. The OXAL action thus is not exclusively connected to the formation of platinum-DNA adducts [16, 24, 25] . The results presented herein lead us to propose that the perturbation by OXAL of IK Ca channels is another intriguing mechanism through ability of this drug and its structurally related compounds to interfere with the proliferative activity of glioma cells, if similar findings occur in vivo. The data also raise the possibility of the OXAL actions on other types of neoplastic cells in which IK Ca (or K Ca 3.1) channels are functionally expressed [5, 8, [13] [14] [15] 20] .
Materials and Methods

Drugs and Solutions
Oxaliplatin (OXAL; trans-1-diaminocyclohexane oxaliplatinum; C 8 H 12 N 2 O 4 Pt) was obtained from Sanofi-Aventis (New York, NY). Ionomycin, lipopolysacharride (LPS), 12-o-tetradecanoylphorbol 13-acetate (TPA; phorbol 12-myristate 13-acetate), tetraethylammonium chloride, triptolide and trypan blue were purchased from Sigma-Aldrich (St. Louis, MO), cisplatin (cis-diaminodichloroplatinum), DCEBIO (5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one), PF573228 and TRAM-34 (1-((2-chlorophenyl) (diphenyl)methyl)-1H-pyrazole) were from Tocirs Cookson Ltd. (Bristol, UK), and tetrodotoxin was from Alomone Labs. (Jerusalem, Israel). All culture media, fetal bovine serum (FBS), L-glutamine, trypsin/EDTA, fungizone and penicillin-streptomycin were obtained from Invitrogen (Carlsbad, CA). All other chemicals were commercially and of reagent grade. Deionized water used throughout the experiments was created from a Milli-Q water purification system (Millipore, Bedford, MA).
The composition of bath solution (i.e., normal Tyrode's solution) was 136.5 mM NaCl, 5. 
Assay of Cell Proliferation
13-06-MG cells (2×104 per ml) were cultured at 37 °C in a 96-well microplate and treated with different concentrations of OXAL. After the exposure to OXAL for 24 hours, 20 µl of methyl tetrazolium (MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) solution (5 mg/ml) was added to each well and cells were incubated for another 4 hours. The formazan crystals were dissolved in 150 µl dimethylsulfoxide and the absorbance of samples was thereafter measured at 490 nm by a microplate reader (model 3550; Bio-Rad Laboratories, CA) [12, 14] .
Trypan blue exclusion assay 13-06-MG cells were maintained in culture medium for 1-3 days. Trypan blue exclusion assay was performed on these cells to determine the number of cells in the absence and presence of OXAL (100 µM). This assay was determined by distinguishing viable (white) from dead cells (blue). The cell number was counted using a hemocytometer (Cambridge Instrument Inc., Somerville, MA) under microscope with a magnification of 100× [10] .
Migration Assay
Chemotactic migration ability of 13-06-MG cells was analyzed by a 64-well Boyden chamber (AP48; Neuro Prob Inc., Gaithersburg, MD). Cells were cultured in serum-free medium for 12 hours. Subsequently, 1×10
7 cells/well were suspended in serum-free DMEM with indicated drugs and placed into the upper chamber of Boyden chamber with a polycarbonate filter (8 µm pore size; GE osmonics labstore, MN). The lower chamber was filled with a medium containing 10% FBS (as a chemoattractant) and indicated drugs. The indicated drugs loaded into both upper and lower chambers are LPS, TPA, or OXAL. After being incubated for indicated times, cells in the upper chamber were cleaned off with cotton swab. The cells present on the lower surface of the filters were fixed with methanol for 10 min. Filters were stained with hematoxylin (Vector Laboratories, CA) for 30 min. Subsequently, the nuclei stained in brown color cells in three different fields of each well were imaged at 20×, counted and averaged as a representative number of migrated cells per field.
RNA Isolation and Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
To detect the expression of KCNMA1 (K Ca 1.1) and KCNN4 (K Ca 3.1) in 13-06-MG cells, a semi-quantitative RT-PCR assay was made. Total RNA samples were extracted from these cells according to TRIzol reagent (Invitrogen) and reverse-transcribed into complementary DNA using Superscript II reverse-transcriptase (Invitrogen). The sequences of forward and reverse primers used for KCNMA1 and KCNN4 are illustrated in Table 1 . In general, the PCR cycling conditions were 35 cycles of 95 °C for 2 min, 95 °C for 20 sec, 60 °C for 20 sec, and 72 °C for 10 min. The PCR products were resolved on 2% agarose gels, analyzed on 1.5% (w/v) agarose gel containing ethidium bromide and then visualized by ultraviolet trans-illumination. The optical densities of DNA bands were then scanned and quantified using Alphalmager 2200 (ProteinSimple; Santa Clara, CA). 
Cellular Physiology and Biochemistry
Electrophysiological Measurements CNS-1, 13-06-MG or LoVo cells were harvested with 1% trypsin/EDTA solution prior to the experiments and a small aliquot of cell suspension was immediately transferred to a recording chamber mounted on the mechanical stage of an inverted fluorescent microscope (CKX-41; Olympus, Tokyo, Japan) coupled to a digital video system (DCR-TRV30; Sony, Tokyo, Japan). Cells were immersed at room temperature (20-25 °C) in normal Tyrode's solution containing 1.8 mM CaCl 2 . Patch electrodes used were pulled from Kimax-51 capillary tubes (#34500; Kimble Glass, Vineland, NJ) using either a PP-83 (Narishige, Tokyo, Japan) or a P-97 Flaming/Brown (Sutter, Novato, CA) puller. Their electrodes had a resistance of 3-5 MΩ when filled with the different pipette solution described above. Ion currents were measured in whole-cell, cell-attached or inside-out configuration of the standard patch-clamp technique using an RK-400 patch amplifier (Bio-Logic, Claix, France) [14, 15, 27, 28] . Junctional potentials between the pipette solution and extracellular medium became nulled prior to seal formation.
The signals, consisting of potential and current traces, were stored online on a TravelMate-6253 laptop computer (Acer, Taipei, Taiwan) at 10 kHz through a Digidata-1440A interface device (Molecular Devices, Sunnyvale, CA), which was controlled by pCLAMP 10.2 software (Molecular Devices). Current signals were low-pass filtered at 3 kHz. Through digital-to-analog conversion, the voltage-step profiles of rectangular or ramp pulses created from pCLAMP 10.2 were used to evaluate the current-voltage (I-V) relationships for different types of ion currents (e.g., I K ) obtained with or with addition of OXAL. Some signals digitally stored through either wired USB or wireless Bluetooth were further analyzed using different tools which include Origin 8.0 (OriginLab, Northampton, MA), LabChart 7.0 program (AD Instruments; Gerin, Tainan, Taiwan), and custom-made macros built in an Excel 2013 spreadsheet under Windows 7 (Microsoft).
Single-Channel Analyses
Single amplitudes of BK Ca -or IK Ca -channel currents were commonly analyzed with pCLAMP 10.2 (Molecular Devices). Multigaussian adjustments of the amplitude distributions among channels were used to determine single-channel events. The number of active channels in a patch was taken as the maximum number of channels simultaneously open under conditions of maximum open probability. The probabilities of channel openings were evaluated using an iterative process to minimize χ 2 values, calculated with an adequately large number of independent observations.
To evaluate concentration-dependent inhibition of OXAL on the probability of IK Ca -channel openings, cells were bathed in normal Tyrode's solution containing 1.8 mM CaCl 2 and each cell examined was held at -80 mV relative to the bath. The channel open probabilities were measured in the control and during cell exposure to different concentrations (3 µM-1 mM) of OXAL, and they were then compared with those measured after subsequent addition of TRAM-34 (3 µM). TRAM-34 is known to be a selective blocker of IK Ca channels [22, 29, 30] . The concentration required to suppress 50% of channel activity was determined by means of a Hill function [28] :
, where [C] represents the OXAL concentration; IC 50 and n H are the concentration required for a 50% inhibition and the Hill coefficient, respectively; and E max indicates the maximal reduction in channel open probability (i.e., TRAM-34-sensitive channel activity) caused by OXAL. 
Calculation of energies among different complexes
With the aid of Chem3D and ChemDraw programs embedded in ChemBio3D Ultra version 14 (PerkinElmer; Waltham, MA), the different parameters for OXAL/Na, OXAL/Ca, cisplatin/Na and cisplatin/ Ca complexes including torsion energy, 1,4-Van der Waals force, and bend, stretch and stretch-bend energies, were calculated and compared [31] .
Statistical Analyses
Data are presented as the mean±standard error of the mean (SEM), with sample sizes (n) indicating the number of cells examined. Paired or unpaired Student's t-test, or one-way analysis of variance with the least-significance difference method for multiple-group comparisons, were used for the statistical evaluation of differences among means. Statistical analyses were performed using IBM SPSS version 20.0 (IBM Corp., Armonk, NY). The non-linear least-squares fitting was generally made using the Solver addin bundled with Excel 2013 (Microsoft, Redmond, WA). Differences were considered significant at P<0.05 unless otherwise indicated.
Results
The mRNA Expression for KCNMA1 (K Ca 1.1) and KCNN4 (K Ca 3.1) in 13-06-MG Cells
We initially examined the mRNA levels of KCNMA1 (K Ca 1.1) and KCNN4 (K Ca 3.1) on 13-06-MG cells. The mRNA expression of these genes was made with a semi-quantitative RT-PCR assay. Our RT-PCR analysis clearly presented the mRNA expression of KCNMA1 (K Ca 1.1) and KCNN4 (K Ca 3.1) in these cells (Fig. 1) . Thus, the results indicate that under our experimental conditions, the mRNA expression of KCNMA1 and KCNN4 channels inherently in these cells can be detected and apparently is not lost in culture.
Effect of OXAL on Whole-Cell K + Current (I K ) in 13-06-MG Cells
In an initial set of experiments, we evaluated whether OXAL exerts any effects on I K in these cells. As cells were bathed in normal Tyrode's solution which contained 1.8 mM CaCl 2 , a family of whole-cell I K were readily elicited ( Fig. 2A) . When cells were exposed to OXAL (100 µM), the amplitudes of I K throughout the entire voltage-clamp examined were progressively diminished (Fig. 2B) . The whole-cell conductance of I K measured between -70 and 0 mV was drastically decreased to 0.57±0.03 nS from a control value of 0.95±0.11 nS (n=11, P<0.05). After washout of OXAL, the I K conductance was returned to 0.61±0.04 nS (n=8). As the difference in current amplitudes at the same level of voltage between the absence and presence of OXAL was taken, the I-V relationship of OXAL-sensitive current in these cells was derived and is depicted in Fig. 2C . However, unexpectedly, as cells were constantly exposed to OXAL, subsequent addition of either DCEBIO (10 µM) or ionomycin (10 µM) was effective in reversing OXAL-mediated inhibition of I K in these cells (Fig. 2D) . DCEBIO is an activator of IK Ca channels, while ionomycin is a Ca 2+ ionophore [22, 30, 32] . These results led us to suggest that the component of K + currents suppressed by OXAL in 13-06-MG cells should be linked to the activity of IK Ca channels [14, 30] . Table 1 .
I K Amplitude Obtained in the Presence of TRAM-34 and TRAM-34 plus OXAL in 13-06-MG Cells
One would expect that the glioma cells exposed to OXAL could alter the effect of TRAM-34, an inhibitor of IK Ca channels, on I K amplitude in 13-06-MG cells. As illustrated in Fig.  3 , the ramp pulse-elicited I K in these cells can be significantly suppressed by TRAM-34 (1 µM). However, in continued presence of TRAM-34, further addition of 100 µM OXAL was not found to decrease I K further. For example, the I K amplitude measured at the level of +40 
Inability of TRAM-34 to Suppress I K in 13-06-MG Cells Preincubated with OXAL
In this study, effect of TRAM-34 on I K was also evaluated in OXAL-treated cells. As depicted in Fig. 4 
in OXAL-treated 13-06-MG cells, addition of TRAM-34 was unable to suppress I K amplitude effectively.
Properties of IK Ca Channels in 13-06-MG Cells
Because the OXAL-mediated inhibition of I K described above may arise from its effects on IK Ca channels, we next examined the electrophysiological and pharmacological properties of single IK Ca -channel currents in 13-06-MG cells. In these experiments, cells were bathed in normal Tyrode's solution containing 1.8 mM CaCl 2 , cell-attached current recordings were performed, and the recording pipette was filled with K + -containing solution described above. As shown in Fig. 5A , in cell-attached patches, the activity of IK Ca channels with spontaneous open and closed transition was readily detected when the cell was held at -80 mV relative to the bath. Under our experimental conditions, the activity of IK Ca channels can be functionally expressed as reported previously in different types of cells [2, 4, [13] [14] [15] . In cell-attached configuration, immediately following addition of 2 mM CaCl 2 or 10 µM ionomycin, IK Ca channels greatly opened with no change in single-channel amplitude. Further addition of 2 mM CaCl 2 and that of 10 µM ionomycin significantly raised channel activity to 0.093±0.021 (n=6, P<0.05) and 0.104±0.0025 (n=7, P<0.05) from a control of 0.031±0.011 (n=9), respectively. These channels are thus sensitive to the level of cytosolic Ca 2+ ions. Additionally, cell exposure to DCEBIO (10 µM) increased the probability of IK Ca -channel openings by 3 folds, while TRAM-34 (1 µM) or clotrimazole (3 µM) was effective at suppressing channel activity by 20% (Fig. 5) . Similar results were also obtained in rat CNS-1 astrocytoma cells. In addition, in continued presence of OXAL (100 µM), subsequent addition of TRAM-34 (1 µM) did not suppress channel activity further (0.006±0.004 pA [in the presence of OXAL, n=8] versus 0.006±0.003 pA [in the presence of OXAL plus TRAM-34, n=8], P>0.05). It is thus clear from these data that the IK Ca channels were functionally expressed in 13-06-MG cells and 
Inhibitory effect of OXAL on the activity of IK Ca channels in 13-06-MG cells
The relationship between the OXAL concentration and the percentage inhibition of IK Cachannel activity was derived and then constructed. In these experiments, each cell was held at -80 mV relative to the bath and the probabilities of channel openings in the absence and presence of different OXAL concentrations were measured. As illustrated in Fig. 6 , OXAL (3 The IC 50 value required for inhibitory effect of OXAL on IK Ca -channel activity in 13-06-MG cells was calculated to be 67 µM, and this drug at a concentration of 1 mM nearly abolished channel activity. Findings from these observations thus indicate that OXAL is capable of exerting a depressant action on the probability of IK Ca -channel openings in these cells.
Effects of OXAL on Single-Channel Conductance of IK Ca Channels
The effect of OXAL on the activity of IK Ca channels at different levels of membrane potentials was also determined. The single-channel amplitudes were increased with greater hyperpolarization. It was also noted that OXAL suppressed the probability of IK Ca -channel openings at different levels of membrane potential (Fig. 7A and 7B) . (Fig. 7C) . These data clearly indicated that despite its inhibitory effects on the activity of IK Ca channels, OXAL exerted little or no effects on single-channel conductance of these channels in 13-06-MG cells. -activated K + channels (e.g., BK Ca channels) can be affected by OXAL in these cells, since the mRNA expresseion of KCNMA1 was detected (Fig. 1) . To detect the activity of BK Ca channels, cells were bathed in high-K + solution which contained 1.8 mM CaCl 2 . Consistent with previous observations [7, 33] , as the cells were held at +60 mV, BK Ca -channel activity can be readily detected (Fig. 8) . After to activate BK Ca channels, while paxilline was effective at inhibiting them [31] . Hence, by comparison, BK Ca channels inherent in these cells is not sensitive to inhibition by OXAL.
Effect of OXAL, OXAL plus
Lack of OXAL to Influence the Inwardly Rectifying K + Current (I K(IR) ) in 13-06-MG Cells
Earlier reports have clearly shown the presence of I K(IR) in glioma cells [6] . We also investigated whether OXAL can exert any effects on I K(IR) functionally expressed in these cells. This set of experiments was conducted in cells which were bathed in Ca 2+ -free high-K + solution. Each cell was held at -50 mV and the up-sloping ramp pulses from -80 to +80 mV were applied. We failed to detect that OXAL at a concentration of 100 µM exerts any effect on the I-V relationship of I K(IR) in these cells (Fig. 9) . On the other hand, addition of BaCl 2 (1 mM) or triptolide (3 µM) alone was effective at suppressing the amplitude of I K(IR) elicited by the ramp pulse. Triptolide was recently reported to suppress I K(IR) effectively in glioma cells [6] . These results reflect that, unlike IK Ca channels, the I K(IR) in these cells is not vulnerable to block by OXAL.
OXAL-Mediated Inhibition of Proliferation and Migration in 13-06-MG Cells
In final set of experiments, the effect of OXAL on the growth in these cells was evaluated. As depicted in Fig. 10A , as OXAL was added to the culture medium of proliferating glioma cells, the rate of cell growth became decreased in a concentration-dependent manner. Moreover, as total cell number was suppressed by OXAL (100 µM), further addition of TRAM-34 (1 µM) did not decrease the proliferation of 13-06-MG cells. At a concentration of 1 mM, OXAL almost fully inhibited cell proliferation. The OXAL concentration required for effective inhibition of IK Ca channels appears to be comparable to that used to suppress cell proliferation in 13-06-MG cells, suggesting that this drug exerts cytotoxic effects in these cells.
We further examined the effect of OXAL on cell viability by trypan blue exclusion assay. As shown in Fig. 10B , after 13-06-MG cells were exposed to OXAL (100 µM) for 1, 2 and 3 days, a significant inhibition in cell growth was observed. However, cell treatment with OXAL (100 µM) for 12 hours did not suppress the proliferation of these cells significantly. The results suggest that OXAL can exert an inhibition of cell growth in a time-dependent fashion. Fig. 10 . OXAL-mediated suppression of cell proliferation (A and B) and migration ability (C) in 13-06-MG cells. In (A), the percentage inhibition of cell growth was calculated in the absence and presence of different concentrations of OXAL. Cell number in the absence and presence of OXAL was measured using colorimetric method described in Materials and Methods. Each bar indicates the mean±SEM derived from four independent experiments with triplicate samples. In (B), the number of viable cells was counted at 1, 2 and 3 days after being incubated with or without 100 µM OXAL. Each point represents the mean±SEM derived from four independent experiments. * Significantly different from controls (i.e., in the absence of OXAL) (P<0.05). In (C), Boyden chamber cell migration assay was used. The cells were induced to migrate by means of the exposure to LPS (0.5 µg/ml) and TPA (400 ng/ml) for 6 hours. The migration ability during exposure to LPS and TPA was taken to be 100% and those in the presence of LPS and TPA plus different OXAL concentrations were measured and compared. Each bar shown in each panel indicates the mean±SEM derived from four independent experiments with triplicate samples. to explore whether the activity of IK Ca channels present in LoVo cells is sensitive to block by OXAL or TRAM-34. Consistent with the observations seen in 13-06-MG glioma cells, OXAL was effective in decreasing the probability of IK Ca -channel openings in LoVo cells (Fig. 11) . For example, when the cells were held at -80 mV relative to the bath, OXAL at a concentration of 100 µM significantly decreased channel activity to 0.022±0.005 (n=11, P<0.05) from a control of 0.092±0.009 (n=11). Therefore, OXAL-induced proliferation of colorectal cancer cells appears to be linked to its perturbation of IK Ca -channel activity.
Discussion
Findings of this study show that (a) in human 13-06-MG glioma cells, OXAL decreases the amplitude of I K in human 13-06-MG glioma cells; (b) DCEBIO or ionomycin can reverse OXALinduced inhibition of I K ; (c) OXAL diminishes the activity of IK Ca channels in a dose-dependent manner, while it did not change single-channel conductance of these channels significantly; (d) neither the activity of BK Ca channels nor I K(IR) amplitude was affected by OXAL; (e) OXAL suppressed cell growth and migration in a concentration-and time-dependent manner in these cells; and (f) this compound decreased the activity of IK Ca channels in LoVo colorectal cancer cells. Therefore, the OXAL-mediated effect on ion channels presented herein may potentially influence the malignant behaviors of glioma cells, if similar in vivo actions exist.
Consistent with previous observations [2] , the activity of IK Ca channels was clearly detected in 13-06-MG cells. The probability of IK Ca -channel openings in these cells can be decreased by TRAM-34 or clotrimazole and be subject to stimulation by DCEBIO. Additionally, It needs to be noted that the OXAL concentration used in our study tends to be greater than that achieved in the plasma of treated patients (3.6-5.6 µM) [35, 36] . Any changes of IK Ca -channel activity suppressed by OXAL depend on not only the OXAL concentration, but also membrane potential, intracellular Ca 2+ concentration and cell volume. Moreover, the OXAL concentrations may not be similar to those present in tissues, because there are areas outside the circulation where OXAL can accumulate at much higher concentrations [36] . For example, heated intraperitoneal chemotherapy was previously demonstrated to produce high peritoneal and tumor OXAL concentrations with limited systemic absorption [37] . One of the reasons could arise from the possibility that OXAL can react with endogenous sulfur compounds (e.g., glutathione) [36, 37] . It has also been shown that in patients heavily pretreated with OXAL, a redistribution of the pool of intra-erythrocytic OXAL biotransformation products into the plasma may aggravate neurotoxic effect of OXAL [38] . Notably, a current study showed that, in heat intraperitoneal chemotherapy with OXAL which is not standard chemotherapy, the OXAL concentrations in tissue can be around 47-85 mg/Kg (118-214 µM) [39] . Additionally, recent investigations have focused on the utilization of different drug-delivery vehicles in facilitating specific delivery of OXAL to tumor tissues [40, 41] . The observed effects by this compound in this study may occur at the range of clinically achievable concentrations, as such maneuvers are implemented to reduce the systemic toxicity.
It needs to be mentioned that cisplatin (100 µM), another platinum-based agent, was not found to have any effects on the activity of IK Ca channels in 13-06-MG cells. OXALinduced inhibition of IK Ca -channel activity may be attributed to an interaction of the oxalate group embedded in this molecule with free Ca 2+ ions [42] . OXAL and its structurally related compounds would be intriguing pharmacological or toxicological tools used to characterize the IK Ca channels.
With the aid of ChemBio3D analysis, the minimal energies for OXAL/Na complex and OXAL/Ca were calculated and compared in our study. Of particular, as Ca 2+ ions are exposed to OXAL, the total energy was greatly changed to -0.0601 kcal/mol. However, the total energies for OXAL/Na complex or cisplatin/Ca complex were 6.3399 and -37.2413 kcal/mol, respectively. The data led us to indicate that, as compared with that of OXAL/Na or cisplatin/ Ca complex, the degree of freedom in OXAL/Ca complex becomes strongly restricted. In OXAL-preincubated cells, addition of TRAM-34 was unable to suppress I K amplitude in 13-06-MG cells. Therefore, the mode of inhibitory action on IK Ca channels and cell proliferation is necessarily linked to an interaction of the OXAL molecule with free Ca 2+ ions [42] , although it can adduct with DNAs that lead to cell death and intracellular generation of reactive oxygen species following the crosslinking with DNAs [18, 24, 25] .
It is also noteworthy that the observed decrease in whole-cell I K by OXAL did not appear to match OXAL-induced decrease in IK Ca -channel activity. The OXAL-induced decrease in I K amplitude was found to be less than its inhibition of IK Ca -channel activity. The reason for this discrepancy is currently unclear. It is possible that the observed I K amplitude was contaminated with other K + currents under whole-cell current recordings. Because the probability of IK Ca -channel openings can be regulated by calmodulin activity [29] , to what extent changes in the level of either intracellular Ca 2+ or calmodulin affect the effects of OXAL on I K remains to be determined.
This study prompts us to propose that, assuming that similar findings observed in this study occur in glial or glioma cells in vivo, any changes in the magnitude of functional [13, 42] . Whether the activators of IK Ca channels or/and suppression of gap junction channels are effective at alleviating OXAL-induced neurotoxicity [23, 34, 41, 43] necessitates further investigation.
